A classification model for G-to-A hypermutation in hepatitis B virus ultra-deep pyrosequencing reads

被引:16
|
作者
Reuman, Elizabeth C. [1 ]
Margeridon-Thermet, Severine [1 ]
Caudill, Harrison B. [1 ]
Liu, Tommy [1 ]
Borroto-Esoda, Katyna [2 ]
Svarovskaia, Evguenia S. [2 ]
Holmes, Susan P. [3 ]
Shafer, Robert W. [1 ]
机构
[1] Stanford Univ, Div Infect Dis, Dept Med, Stanford, CA 94305 USA
[2] Gilead Sci Inc, Foster City, CA 94404 USA
[3] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
RESISTANCE; GENOMES;
D O I
10.1093/bioinformatics/btq570
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: G -> A hypermutation is an innate antiviral defense mechanism, mediated by host enzymes, which leads to the mutational impairment of viruses. Sensitive and specific identification of host-mediated G -> A hypermutation is a novel sequence analysis challenge, particularly for viral deep sequencing studies. For example, two of the most common hepatitis B virus (HBV) reverse transcriptase (RT) drug-resistance mutations, A181T and M204I, arise from G -> A changes and are routinely detected as low-abundance variants in nearly all HBV deep sequencing samples. Results: We developed a classification model using measures of G -> A excess and predicted indicators of lethal mutation and applied this model to 325 920 unique deep sequencing reads from plasma virus samples from 45 drug treatment-naive HBV-infected individuals. The 2.9% of sequence reads that were classified as hypermutated by our model included most of the reads with A181T and/or M204I, indicating the usefulness of this model for distinguishing viral adaptive changes from host-mediated viral editing.
引用
收藏
页码:2929 / 2932
页数:4
相关论文
共 50 条
  • [31] Analysis of co-selection of immune escape and treatment- resistant variants in Hepatitis B virus quasispecies by ultra-deep pyrosequencing in lamivudine-treated patients
    Tabernero, David
    Rodriguez-Frias, Francisco
    Casillas, Rosario
    Gregori, Josep
    Quer, Josep
    Mosquera, Marta
    Camos, Silvia
    Ramirez, Clara
    Homs, Maria
    Esteban, Rafael
    Buti, Maria
    HEPATOLOGY, 2012, 56 : 425A - 426A
  • [32] Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients
    Margeridon-Thermet, Severine
    Shulman, Nancy S.
    Ahmed, Aijaz
    Shahriar, Rajin
    Liu, Tommy
    Wang, Chunlin
    Holmes, Susan P.
    Babrzadeh, Farbod
    Gharizadeh, Baback
    Hanczaruk, Bozena
    Simen, Birgitte B.
    Egholm, Michael
    Shafer, Robert W.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (09): : 1275 - 1285
  • [33] Long-term monitoring drug resistance by ultra-deep pyrosequencing in a chronic hepatitis B virus (HBV)-infected patient exposed to several unsuccessful therapy schemes
    Sede, M.
    Ojeda, D.
    Cassino, L.
    Westergaard, G.
    Vazquez, M.
    Benetti, S.
    Fay, F.
    Tanno, H.
    Quarleri, J.
    ANTIVIRAL RESEARCH, 2012, 94 (02) : 184 - 187
  • [34] Analysis of Ultra-Deep Pyrosequencing and Cloning Based Sequencing of the Basic Core Promoter/Precore/Core Region of Hepatitis B Virus Using Newly Developed Bioinformatics Tools
    Yousif, Mukhlid
    Bell, Trevor G.
    Mudawi, Hatim
    Glebe, Dieter
    Kramvis, Anna
    PLOS ONE, 2014, 9 (04):
  • [35] Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing
    Caro-Perez, Noelia
    Martinez-Rebollar, Maria
    Gregori, Josep
    Quer, Josep
    Gonzalez, Patricia
    Gambato, Martina
    Garcia-Gonzalez, Neris
    Gonzalez-Candelas, Fernando
    Costa, Josep
    Ignacio Esteban, Juan
    Mallolas, Josep
    Forns, Xavier
    Laguno, Montse
    Perez-del-Pulgar, Sofia
    JOURNAL OF CLINICAL VIROLOGY, 2017, 92 : 42 - 47
  • [36] Analysis of hepatitis B virus-mixed genotype infection by ultra deep pyrosequencing in Sudanese patients, 2015–2016
    Khalid Abdallah Enan
    Claudia Minosse
    Abdel Rahim Mohammed El Hussein
    Marina Selleri
    Emanuela Giombini
    Maria Rosaria Capobianchi
    Isam Mohamed Elkhidir
    Mohamed Omer Mustafa
    Osama Mohamed Khair
    Dina Ahamed Hassan
    Anna Rosa Garbuglia
    Infection, 2019, 47 : 793 - 803
  • [37] Post-Treatment Viral Evolution Assessment Using Ultra-Deep Pyrosequencing in Samples from Patients with Hepatitis C Virus Infection: The EXTEND Study
    Dierynck, Inge
    Thys, Kim
    Bartels, Doug J.
    Ghys, Anne
    Van Rossem, Elizabeth
    Zhang, Eileen Z.
    Davis, Andrew
    Friedman, Mark I.
    Kieffer, Tara L.
    Aerssens, Jeroen
    De Meyer, Sandra
    Sullivan, James C.
    HEPATOLOGY, 2013, 58 : 939A - 940A
  • [38] Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing
    Nishijima, Norihiro
    Marusawa, Hiroyuki
    Ueda, Yoshihide
    Takahashi, Ken
    Nasu, Akihiro
    Osaki, Yukio
    Kou, Tadayuki
    Yazumi, Shujiro
    Fujiwara, Takeshi
    Tsuchiya, Soken
    Shimizu, Kazuharu
    Uemoto, Shinji
    Chiba, Tsutomu
    PLOS ONE, 2012, 7 (04):
  • [39] PREVALENCE OF NUCLEOSIDE/NUCLEOTIDE ANALOGUE RESISTANCE AMONG TREATMENT-NAIVE ENDEMICALLY-EXPOSED CHRONIC HEPATITIS B INDIVIDUALS BY ULTRA-DEEP PYROSEQUENCING
    Osiowy, Carla
    Ng, Karen A.
    Ho, John
    Liang, Ben
    Wong, David K.
    Van Domselaar, Gary
    Heathcote, E. Jenny
    HEPATOLOGY, 2011, 54 : 1067A - 1068A
  • [40] Analysis of hepatitis B virus-mixed genotype infection by ultra deep pyrosequencing in Sudanese patients, 2015-2016
    Enan, Khalid Abdallah
    Minosse, Claudia
    El Hussein, Abdel Rahim Mohammed
    Selleri, Marina
    Giombini, Emanuela
    Capobianchi, Maria Rosaria
    Elkhidir, Isam Mohamed
    Mustafa, Mohamed Omer
    Khair, Osama Mohamed
    Hassan, Dina Ahamed
    Garbuglia, Anna Rosa
    INFECTION, 2019, 47 (05) : 793 - 803